SUMO in cancer - Wrestlers wanted

Cancer Biology and Therapy

Volumn 1, Issue 3, 2002, Pages 237-242

  Alarcon Vargas, Dania ^a   Ronai, Ze'ev ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUMO PROTEIN; UBIQUITIN;

CELL CYCLE; DRUG ANTAGONISM; GENETIC TRANSCRIPTION; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW;

CELL CYCLE; HUMANS; NEOPLASMS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTION, GENETIC; UBIQUITINS;

EID: 0042574401     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.74     Document Type: Review

References (71)

1. Seeler JS, Dejean A. SUMO: of branched proteins and nuclear bodies. Oncogene 2001; 20:7243-9. (Pubitemid 33105013)
2. Bayer P, Arndt A, Metzger S, Mahajan R, Melchior F, Jaenicke R, et al. Structure determination of the small ubiquitin-related modifier SUMO-1. J Mol Biol 1998; 280:275-86. (Pubitemid 28325519)
3. Melchior F. SUMO-nonclassical ubiquitin. Annu Rev Cell Dev Biol 2000; 16:591-626.
4. Johnson ES, Schwienhorst I, Dohmen RJ, Blobel G. The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J 1997; 16:5509-19. (Pubitemid 27399843)
5. Desterro JM, Rodriguez MS, Kemp GD, Hay RT. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J Biol Chem 1999; 274:10618-24.
6. Gong L, Li B, Millas S, Yeh ET. Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex. FEBSLetters 1999; 448:185-9. (Pubitemid 29151657)
7. Okuma T, Honda R, Ichikawa G, Tsumagari N, Yasuda H. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochem Biophys Res Comm 1999; 254:693-8.
8. Schwarz SE, Matuschewski K, Liakopoulos D, Scheffner M, Jentsch S. The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. PNAS 1998; 95:560-4. (Pubitemid 28083782)
9. Desterro JMP, Thomson J, Hay RT. Ubch9 conjugates SUMO but not ubiquitin. FEBS Letters 1997; 417:297-300. (Pubitemid 27511608)
10. Kurtzman AL, Schechter N. Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification. PNAS 2001; 98:5602-7. (Pubitemid 32435688)
11. Rodriguez MS, Dargemont C, Hay RT. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem 2001; 276:12654-9.
12. Sampson DA, Wang M, Matunis MJ. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J Biol Chem 2001; 276:21664-9.
13. Mahajan R, Delphin C, Guan T, Gerace L, Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 1997; 88:97-107. (Pubitemid 27180334)
14. Pichler A, Gast A, Seeler JS, Dejean A, Melchior F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 2002; 108:109-120. (Pubitemid 34137016)
15. Johnson ES, Gupta AA. An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 2001; 106:735-44. (Pubitemid 32900664)
16. Takahashi Y, Kahyo T, Toh-E A, Yasuda H, Kikuchi Y.Yeast Ull1/Siz1 is a novel SUMO1/Smt3 ligase for septin components and functions as an adaptor between conjugating enzyme and substrates. J Biol Chem 2001a; 276:48973-7.
17. Takahashi Y, Toh-e A, Kikuchi Y. A novel factor required for the SUMO1/Smt3 conjugation of yeast septins. Gene 2001b; 275:223-31. (Pubitemid 32918351)
18. Kahyo T, Nishida T, Yasuda H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell 2001; 8:713-8. (Pubitemid 32946947)
19. Sachdev S, Bruhn L, Sieber H, Pichler A, Melchior F, Grosschedl R. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes & Dev 2001; 15:3088-103. (Pubitemid 33115674)
20. Hochstrasser M. SP-RING for SUMO: new functions bloom for a ubiquitin-like protein. Cell 2001; 107:5-8. (Pubitemid 32972031)
21. Jackson PK. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes & Dev 2001; 15:3053-8. (Pubitemid 33115672)
22. Saitoh H, Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem 2000; 275:6252-8. (Pubitemid 30129915)
23. Tatham MH, Jaffray E, Vaughan OA, Desterro JMP, Botting CH, Naismith JH et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem 2001; 276:35368-74.
24. Li SJ, Hochstrasser M. A new protease required for cell-cycle progression in yeast. Nature 1999; 398:246-51.
25. Schwienhorst I, Johnson ES, Dohmen RJ. SUMO conjugation and deconjugation. Mol Gen Genet 2000; 263:771-86.
26. Li SJ, Hochstrasser M. The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein. Mol Cell Biol 2000; 20:2367-77. (Pubitemid 30152045)
27. Gong L, Millas S, Maul GG, Yeh ET. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J Biol Chem 2000; 275:3355-9. (Pubitemid 30083039)
28. Kim KI, Baek SH, Jeon YJ, Nishimori S, Suzuki T, Uchida S, et al. A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J Biol Chem 2000; 275:14102-6. (Pubitemid 30339685)
29. Suzuki T, Ichiyama A, Saitoh H, Kawakami T, Omata M, Chung CH, et al. A new 30-kDa ubiquitin-related SUMO-1 hydrolase from bovine brain. J Biol Chem 1999; 274:31131-4.
30. Nishida T, Tanaka H, Yasuda H. A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur J Biochem 2000; 267:6423-7.
31. Nishida T, Kaneko F, Kitagawa M, Yasuda H. Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat axam, which is an axin-binding protein promoting beta-catenin degradation. J Biol Chem 2001; 276:39060-6.
32. Sternsdorf T, Jensen K, Will H. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol 1997; 139:1621-34. (Pubitemid 28079228)
33. Muller S, Matunis MJ, Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 1998; 17:61-70. (Pubitemid 28041048)
34. Sternsdorf T, Jensen K, Reich B, Will H. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem 1999; 274:12555-66.
35. Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN, et al SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localization. J Cell Sci 1999; 112:381-93. (Pubitemid 29080660)
36. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, et al. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 1999; 147:221-33. (Pubitemid 29496333)
37. Zhong S, Muller S, Ronchetti S, et al. Role of SUMO-1-modified PML in nuclear body formation. Blood 2000; 95:2748-53. (Pubitemid 30235878)
38. Lehembre F, Muller S, Pandolfi PP, Dejean A. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Oncogene 2001; 20:1-9. (Pubitemid 32142332)
39. Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K, et al. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J 2000; 19:6185-95.
40. Muller S, Berger M, Lehembre F, Seeler JS, Haupt Y, Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem 2000; 275:13321-9. (Pubitemid 30257389)
41. Buschmann T, Fuchs SY, Lee CG, Pan ZQ, Ronai Z. SUMO-1 modification of mdm2 prevents its self-ubiquitination and increases mdm2 ability to ubiquitinate p53. Cell 2000; 101:753-62.
42. Buschmann T, Lerner D, Lee CG, Ronai Z. The mdm-2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9. J Biol Chem 2001; 276:40389-95.
43. Bies J, Markus J, Wolff L. Covalent attachment of SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J Biol Chem 2002; 10:1074.
44. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT. SUMO-1 modification activates the transcriptional response of p53. EMBO J 1999; 18:6455-61. (Pubitemid 29533249)
45. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M, et al. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 1999; 18:6462-71. (Pubitemid 29533250)
46. Kwek SS, Derry J, Tyner AL, Shen Z, Gudkov AV. Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene 2001; 20:2587-99. (Pubitemid 32531356)
47. Schmidt D, Muller S. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci USA 2002; 99:2872-7. (Pubitemid 34240553)
48. Minty A, Dumont X, Kaghad M, Caput D. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J Biol Chem 2000; 275:36316-23.
49. Johnson ES, Blobel G. Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins. J Cell Biol 1999; 147:981-93.
50. Takahashi Y, Iwase M, Konishi M, Tanaka M, Toh-e A, Kikuchi Y. Smt3, a SUMO-1 homolog, is conjugated to Cdc3, a component of septin rings at the mother-bud neck in budding yeast. Biochem Biophys Res Comm 1999; 259:582-7. (Pubitemid 29335576)
51. Mannen H, Tseng HM, Cho CL, Li SS. Cloning and expression of human homologue of HSMT3 to yeast SMT3 suppressor of MIF2 mutations in a centromere protein gene. Biochem Biophys Res Comm 1996; 222:178-80. (Pubitemid 26152224)
52. Fukagawa T, Regnier V, Ikemura T. Creation and characterization of temperature-sensitive CENP-C mutants in vertebrate cells. Nucleic Acids Res 2001; 29:3796-803. (Pubitemid 32910520)
53. Mossessova E, Lima CD. Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol Cell 2000; 5:865-76.
54. Tanaka K, Nishide J, Okazaki K, Kato H, Niwa O, Nakagawa T, et al. Characterization of a fission yeast SUMO-1 homologue, pmt3p, required for multiple nuclear events, including the control of telomere length and chromosome segregation. Mol Cell Biol 1999; 19:8660-72. (Pubitemid 30414058)
55. Kawabe YI, Seki M, Seki T, Wang WS, Imamura O, Furuichi Y, et al. Covalent modification of the Werner's syndrome gene product with the ubiquitin-related protein, SUMO-1. J Biol Chem 2000; 275:20963-6. (Pubitemid 30481783)
56. Desterro JMP, Rodriguez MS, Hay RT. SUMO-1 modification of IκBα inhibits NFκB activation. Mol Cell 1998; 2:233-9. (Pubitemid 128373648)
57. Hay RT, Vuillard L, Desterro JM, Rodriguez MS. Control of NFκB transcriptional activation by signal induced proteolysis of IκBα. Phil Trans R Soc Lond 1999; 354:1601-9. (Pubitemid 29464091)
58. Bhaskar V, Valentine SA, Courey AJ. A functional interaction between dorsal and components of the Smt3 conjugation machinery. J Biol Chem 2000; 275:4033-40. (Pubitemid 30094632)
59. Mao Y, Sun M, Desai SD, Liu LF. SUMO-1 conjugation to topoisomerase I: a possible repair response to topoisomerase-mediated DNA damage. PNAS 2000; 97:4046-51. (Pubitemid 30226084)
60. Mao Y, Desai SD, Liu LF. SUMO-1 conjugation to human DNA topoisomerase II isozymes. J Biol Chem 2000; 275:26066-73.
61. Mo YY, Yu Y, Shen Z, Beck WT. Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the protein. J Biol Chem 2002; 277:2958-64. (Pubitemid 34953331)
62. Hong Y, Rogers R, Matunis MJ, Mayhew CN, Goodson M, Park-Sarge OK, et al. Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J Biol Chem 2001; 276:40263-7.
63. Goodson ML, Hong Y, Rogers R, Matunis MJ, Park-Sarge OK, Sarge KD. SUMO-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor. J Biol Chem 2001; 276:18513-8.
64. Poukka H, Aarnisalo P, Karvonen U, Palvimo JJ, Janne OA. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J Biol Chem 1999; 274:19441-6.
65. Poukka H, Karvonen U, Janne OA, Palvimo JJ. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). PNAS 2000; 97:14145-50. (Pubitemid 32016544)
66. Muller S, Dejean A. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J Virol 1999; 73:5137-43. (Pubitemid 29246776)
67. Adamson AL, Kenney S. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol 2001; 75:2388-99. (Pubitemid 32147577)
68. Hofmann H, Floss S, Stamminger T. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J Virol 2000; 74:2510-24. (Pubitemid 30117560)
69. Rangasamy D, Woytek K, Khan SA, Wilson VG. SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation. J Biol Chem 2000; 275:37999-8004. (Pubitemid 32004922)
70. Endter C, Kzhyshkowska J, Stauber R, Dobner T. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. PNAS 2001; 98:11312-7. (Pubitemid 32928725)
71. Wilson VG, Rangasamy D. Viral interaction with the host cell sumoylation system. Virus Res 2001; 81:17-27. (Pubitemid 33001360)